ADPT short interest
Adaptive Biotechnologies Corporation · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 11,843,887 |
|---|---|
| Change vs prior report | -1,645,694 (-12.2%) |
| Change over six months | +38.4% |
| Days to cover | 4.43 (sector: 3.78) |
| Average daily volume | 2,674,025 |
| Rank in Healthcare | #469 of 922 by days to cover |
ADPT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 11,843,887 | -12.2% | 4.43 | 2,674,025 |
| 2026-09-15 | 13,489,581 | +15.2% | 7.89 | 1,708,828 |
| 2026-08-31 | 11,712,796 | -12.1% | 6.37 | 1,839,973 |
| 2026-08-14 | 13,323,767 | +6.7% | 5.72 | 2,329,412 |
| 2026-07-31 | 12,490,395 | +9.6% | 4.39 | 2,844,419 |
| 2026-07-15 | 11,396,387 | +0.4% | 4.31 | 2,645,741 |
| 2026-06-30 | 11,352,839 | +48.5% | 2.23 | 5,086,171 |
| 2026-06-15 | 7,645,147 | -7.2% | 2.82 | 2,708,847 |
| 2026-05-29 | 8,240,744 | -7.4% | 5.13 | 1,606,754 |
| 2026-05-15 | 8,897,341 | +5.4% | 4.55 | 1,955,224 |
| 2026-04-30 | 8,439,712 | -1.3% | 6.94 | 1,216,819 |
| 2026-04-15 | 8,551,420 | -0.1% | 4.41 | 1,936,987 |
| 2026-03-31 | 8,558,955 | -7.4% | 4.06 | 2,110,288 |
| 2026-03-13 | 9,247,322 | +4.2% | 3.65 | 2,530,853 |
| 2026-02-27 | 8,877,604 | -3.4% | 6.51 | 1,364,625 |
| 2026-02-13 | 9,193,089 | +1.8% | 4.27 | 2,153,033 |
| 2026-01-30 | 9,033,105 | +0.1% | 5.56 | 1,623,391 |
| 2026-01-15 | 9,021,329 | +3.0% | 4.01 | 2,247,383 |
| 2025-12-31 | 8,760,209 | -10.1% | 4.43 | 1,975,967 |
| 2025-12-15 | 9,742,510 | -6.3% | 2.94 | 3,315,759 |
| 2025-11-28 | 10,403,303 | +0.3% | 3.75 | 2,775,932 |
| 2025-11-14 | 10,368,382 | +15.1% | 4.98 | 2,082,975 |
| 2025-10-31 | 9,010,315 | -0.2% | 5.84 | 1,544,106 |
| 2025-10-15 | 9,027,063 | -5.9% | 4.96 | 1,821,457 |
| 2025-09-30 | 9,588,547 | +2.6% | 4.65 | 2,062,003 |
import finzdata as yf
yf.Ticker("ADPT").short_interest # every report since 2017
yf.Client().short_interest(["ADPT"], start="2018-01-01")Healthcare short interest · ADPT price history · Who owns ADPT · All short interest